NCT06896890 2025-03-26Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung CancerInhatarget TherapeuticsPhase 1/2 Recruiting32 enrolled
NCT05303376 2023-09-13Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 IllnessImmune Biosolutions IncPhase 1/2 Completed123 enrolled